Recode

ReCode Therapeutics is a clinical-stage biotech company focused on developing genetic medicines for rare diseases. Their proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform enables precise and targeted delivery of genetic medicines directly to the organs, tissues, and cells implicated in disease, overcoming the limitations of current delivery systems. This advanced delivery technology allows for improved efficacy and potency, opening up new possibilities for treating a wide range of genetic conditions.

ReCode's lead programs include RCT1100 for primary ciliary dyskinesia (PCD) and RCT2100 for cystic fibrosis (CF), both of which are inhaled disease-modifying mRNA-based therapies. The company is actively expanding its pipeline to develop potential therapies for other rare and common genetic diseases, including musculoskeletal, central nervous system, liver, and infectious disease indications. ReCode's commitment to innovation and its unique SORT LNP platform make it a leading player in the burgeoning field of genetic medicines.

ReCode Therapeutics is a company based in Menlo Park, CA that offers a number of flexible work options. The company website lists three open positions, all of which are based in Menlo Park. While there is no mention of remote work possibilities, ReCode has been recognized as a Best Place to Work in the Bay Area, suggesting a positive and employee-centric culture.

ReCode Therapeutics is a clinical-stage genetic medicines company focused on developing novel mRNA and gene correction therapeutics for genetically defined diseases with limited or no existing treatment options. Their mission is to power the next wave of genetic medicine by leveraging their proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform, which enables precise and targeted delivery of genetic medicines directly to the organs, tissues, and cells implicated in disease. This platform has the potential to transcend the limitations of current genetic medicine delivery systems, enabling improved efficacy and potency for a wide range of genetic disorders.

ReCode Therapeutics cultivates a culture that values curiosity, kindness, and authenticity. They encourage their employees to act with urgency, take ownership of their work, and strive to generate groundbreaking science. The company emphasizes collaboration and a shared sense of purpose, prioritizing teamwork and camaraderie to achieve impactful results for patients. They also demonstrate a commitment to diversity and inclusion, fostering an environment where different perspectives are welcomed and valued.

ReCode Therapeutics embraces a culture of exploration and belonging, prioritizing diversity, equity, and inclusion. They value curiosity, kindness, and authenticity, encouraging employees to be themselves and contribute their unique perspectives. Their commitment to diversity is evident in their team composition, with a focus on building a diverse team of individuals who think differently and bring new ideas to the table. They also emphasize acting with urgency and efficiency, fostering an environment where employees have the autonomy to be bold and drive positive change. Ultimately, ReCode strives to create a workplace where everyone feels valued, respected, and empowered to make a difference.